Zilucoplan
Protein
Overview
Zilucoplan is a protein active pharmaceutical ingredient (ChEMBL CHEMBL4298207).
Patent & exclusivity (US)
Per the FDA Orange Book (3 approved US products), the latest listed US patent on Zilucoplan expires 12 Jun 2035 and exclusivity 17 Oct 2030. Generic API sourcing typically opens up once these lapse.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.